TRANSVASKULÄRE NERVENSTIMULATIONSVORRICHTUNG

European patent · EP3556427 · In force

Register entry

Publication number
EP3556427
Application number
EP19178080
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 4, 2013
Published
Oct 23, 2019
Granted
Jun 8, 2022
Protection ends at the latest
Mar 3, 2033
Next annual fee due
Mar 31, 2027
IPC classes
A61N 1/05 (2006.01)
A61N 1/36 (2006.01)
Priority
US 201261606899 P 05.03.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 2, 2024

    Change

    Published in Swissreg on 02.04.2024

  4. Apr 19, 2023

    Change

    Published in Swissreg on 19.04.2023

  5. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  6. Aug 15, 2022

    Agent entered

    Representative
    Hepp Wenger Ryffel AG, Friedtalweg 5, 9500 Wil

    Published in Swissreg on 15.08.2022

  7. Jun 8, 2022

    Granted

    Published in Swissreg on 08.06.2022

Parties

Holder

Lungpacer Medical Inc.

8602 Commerce Court, Burnaby BC V5A 4N6, CA

Agent

Hepp Wenger Ryffel AG

Friedtalweg 5, 9500 Wil

Inventor

HOFFER, Joaquin Andres

Anmore, British Columbia V3H 5E9, CA

THAKKAR, Viral

Chester Springs, Pennsylvania 19425, US

TRAN, Bao Dung

Vancouver, British Columbia V5P 2Y5, CA

NOLETTE, Marc-Andre

Burnaby, British Columbia V5C 2B9, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.